398 studies found for:    Open Studies | Exclude Unknown | "heart disease"OR"stroke"OR"cardiovascular disease" | United States | Phase 1, 2, 3, 0 | Industry
Show Display Options
Rank Status Study
21 Not yet recruiting ASIS for Botox in Upper Limb Spasticity
Conditions: Upper Limb Spasticity Unilaterally in Adults With History of Stroke;   Increased Muscle Tone in Elbow, Wrist, Finger, and Thumb Flexors.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Botox intramuscularly at Week 6;   Drug: Efficacy of Botox intramuscularly at Week 12,;   Drug: Efficacy of Botox intramuscularly at Week 18;   Drug: Efficacy of Botox intramuscularly at Week 24;   Drug: Efficacy of Botox intramuscularly at Week 30;   Drug: Efficacy of Botox subdermally at Week 6;   Drug: Efficacy of Botox subdermally at Week 12;   Drug: Efficacy of Botox subdermally at Week 18;   Drug: Efficacy of Botox subdermally at Week 24;   Drug: Efficacy of Botox subdermally at Week 30;   Drug: Adverse Reactions of Botox intramuscularly;   Drug: Adverse Reactions of Botox subdermally
22 Recruiting BOTOX® Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Interventions: Biological: botulinum toxin Type A;   Drug: Normal Saline (Placebo)
23 Recruiting BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
Conditions: Pediatrics;   Muscle Spasticity;   Cerebral Palsy;   Stroke
Intervention: Biological: botulinum toxin Type A
24 Recruiting Computerized Attention Training for Individuals With Acquired Brain Injury
Conditions: Acquired Brain Injury;   Stroke;   Hemispatial Neglect
Interventions: Behavioral: Tonic and Phasic Attention Training;   Behavioral: Active Comparator
25 Recruiting Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions
Conditions: Stroke;   Brain Ischemia;   Vasospasm, Intracranial;   Hemorrhage, Intracranial
Interventions: Drug: Dexmedetomidine;   Drug: Fentanyl;   Drug: Midazolam
26 Recruiting Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities
Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat;   Drug: Allopurinol
27 Recruiting The Evaluation Of PF-04950615 (RN316), In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
Condition: Cardiovascular Disease
Interventions: Drug: PF-04950615;   Drug: Placebo
28 Recruiting The Evaluation Of PF-04950615 (RN316) In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects
Condition: Cardiovascular Disease
Interventions: Drug: PF-04950615;   Drug: Placebo
29 Recruiting Study of Botulinum Toxin and Recovery of Hand Function After Stroke
Condition: Stroke With Hemiparesis
Intervention: Drug: Botulinum Toxin commonly known as BOTOX®
30 Recruiting The Fibrin Pad CV Phase III Study
Condition: Cardiovascular Disease
Interventions: Biological: EVARREST™ Fibrin Sealant Patch;   Biological: Topical hemostat
31 Recruiting MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients
Condition: Acute Stroke
Intervention: Drug: IV rt-PA
32 Recruiting Safety & Efficacy of Adipose-Derived Regenerative Cells in the Treatment of Chronic Myocardial Ischemia (ATHENA II)
Condition: Myocardial Ischemia
Interventions: Device: Adipose-Derived Regenerative Cells (ADRCs) - Celution System;   Device: Placebo - Physiological Solution
33 Recruiting Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease
Condition: Atherosclerotic Coronary Vascular Disease
Intervention: Drug: Ranolazine
34 Recruiting Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial
Condition: Ischemic Attack, Transient
Interventions: Drug: Clopidogrel;   Drug: placebo
35 Recruiting Antithrombin III in Infants With Cardiopulmonary Bypass (CPB)
Condition: Congenital Heart Disease
Interventions: Drug: Antithrombin III;   Drug: Placebo
36 Recruiting A Study of the Efficacy and Safety of Activase (Alteplase) in Patients With Mild Stroke (PRISMS)
Condition: Brain Ischemia
Interventions: Drug: alteplase [Activase];   Drug: alteplase placebo;   Drug: aspirin;   Drug: aspirin placebo
37 Recruiting Multicenter Trial to Evaluate the Effect of Dapagliflozin on the Incidence of Cardiovascular Events
Conditions: Diabetes Mellitus, Non-Insulin-Dependent;   High Risk for Cardiovascular Event
Interventions: Drug: Dapagliflozin 10 mg;   Drug: Placebo tablet
38 Recruiting Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation
Condition: Paroxysmal Atrial Fibrillation (PAF)
Interventions: Device: Blazer Open-Irrigated Ablation Catheter (Boston Scientific);   Device: FDA Approved Open-Irrigated Ablation Catheter
39 Recruiting A Pivotal Trial to Establish the Efficacy and Long-term Safety of the Parachute Implant System
Conditions: Congestive Heart Failure;   Left Ventricular (LV) Systolic Dysfunction
Intervention: Device: CardioKinetix Parachute Implant and All Appropriate Medical Therapy (AAMT)
40 Recruiting Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary Disease
Condition: Pulmonary Disease, Chronic Obstructive
Interventions: Drug: fluticasone furoate/vilanterol;   Drug: fluticasone furoate;   Drug: vilanterol;   Other: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years